{"SPADE_N_02452": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 5428016 A", "Patent Link": "http://www.lens.org/lens/patent/US_5428016_A", "Patent Type": "Granted Patent", "Publication Date": "1995-6-27", "Family Info": "CA2063063A1,CA2063063C,DE69220397D1,DE69220397T2,EP0503939A1,EP0503939B1", "Patent Title": "Antimicrobial peptide and antimicrobial agent.", "Abstract": "An antimicrobial peptide containing at least the following amino acid sequence, or a derivative thereof, an antimicrobial agent containing said antimicrobial peptide or a derivative thereof as active components at a concentration of at least 1 µM, an antimicrobial composition containing said antimicrobial peptide or a derivative thereof, and a method for processing products which uses the antimicrobial agent containing at least said antimicrobial peptide or a derivative thereof: EQU A--X--A (where, A is an arginine residue or a lysine residue; and X is an amino acid sequence comprising at least from three to nine arbitrary amino acid residues other than cysteine residues)."}], "Sequence Information": {"SPADE ID": "SPADE_N_02452", "Peptide Name": "LfcinB(20-25)", "Source": "bovine", "Family": "bovine LfcinB", "Gene": "LTF", "Sequence": "RRWQWR", "Sequence Length": 6, "UniProt Entry": ["http://www.uniprot.org/uniprot/P24627"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram+"], "Target Organism": "[Ref.29984236] Gram-positive bacterium:Staphylococcus aureus ATCC 33591 (MIC=100 μg/ml; MBC=199 μg/ml)", "Hemolytic Activity": "[Ref.29984236] 3% hemolysis at 5 μM, 5% hemolysis at 12 μM, 5% hemolysis at 22 μM, 0% hemolysis at 50 μM, 2% hemolysis at 100 μM against human red blood cell.[Ref.29551999] 7.1% hemolysis at 25μM, 50% hemolysis at >100μM against human red blood cells.", "Cytotoxicity": "Not included yet", "Binding Target": "Not found", "Linear/Cyclic": "Not included yet", "N-terminal Modification": "Not included yet", "C-terminal Modification": "Not included yet", "Stereochemistry": "Not included yet", "Structure Description": "Not found", "Formula": "C45H66N18O8", "Mass": 987.12, "PI": 12.0, "Net Charge": 3, "Hydrophobicity": -3.13, "Half Life": "Mammalian:1 hourYeast:2 minE.coli:2 min", "Function": "Antibacterial activity against the Gram-negative bacteria and Gram-positive bacteria. Has hemolytic activity.", "Literature": [{"Title": "Effect of Polyvalence on the Antibacterial Activity of a Synthetic Peptide Derived from Bovine Lactoferricin against Healthcare-Associated Infectious Pathogens.", "Pubmed ID": "29984236", "Reference": "Biomed Res Int. 2018 Jun 10;20185252891", "Author": "Sandra C. Vega Chaparro, J. Tatiana Valencia Salguero, Diana A. Mart", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=29984236"}, {"Title": "Design, Synthesis and Evaluation of Branched RRWQWR-Based Peptides as Antibacterial Agents against Clinically Relevant Gram-Positive and Gram-Negative Pathogens", "Pubmed ID": "29551999", "Reference": "Front Microbiol. 2018 Mar 2;9329.", "Author": "Nguyen LT, Chau JK, Perry NA, de Boer L, Zaat SA, Vogel HJ", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=29551999"}, {"Title": "Serum stabilities of short tryptophan- and arginine-rich antimicrobial peptide analogs", "Pubmed ID": "20844765", "Reference": "PLoS One. 2010 Sep 10;5(9)e12684. doi 10.1371/journal.pone.0012684", "Author": "", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=20844765"}], "Frequent Amino Acids": "RWQ", "Absent Amino Acids": "ACDEFGHIKLMNOPSTUVY", "Basic Residues": 3, "Acidic Residues": 0, "Hydrophobic Residues": 2, "Polar Residues": 4, "Positive Residues": 3, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_02451", "Similarity": 1.0, "Sequence": "FKCRRWQWRMKKLGAPSITCVRRAF"}, {"SPADE_ID": "SPADE_N_02472", "Similarity": 1.0, "Sequence": "QVVRNPQSCRWNMGVCIPISCPGNMRQIGTCFGPRVPCCRRW"}, {"SPADE_ID": "SPADE_N_02473", "Similarity": 1.0, "Sequence": "QGVRNHVTCRIYGGFCVPIRCPGRTRQIGTCFGRPVKCCRRW"}]}}}